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ABSTRACT 
 
 
Tanataweethum, Nida. M.S.B.M.E., Purdue University, December 2013. Mechanical 
Property and Biocompatibility of PLLA Coated DCPD Composite Scaffolds. Major 
Professor: T.M. Gabriel Chu. 
 
Dicalcium phosphate dihydrate (DCPD) cements have been used for bone repair 
due to its excellent biocompatibility and resorbability. However, DCPD cements are 
typically weak and brittle. To overcome these limitations, the sodium citrate used as a 
setting regulator and the coating of poly-L-lactide acid (PLLA) technique have been 
proposed in this study. The first purpose of this thesis is to develop composite PLLA/ 
DCPD scaffolds with enhanced toughness by PLLA coating. The second purpose is to 
examine the biocompatibility of the scaffolds. The final purpose is to investigate the 
degradation behaviors of DCPD and PLLA/DCPD scaffolds. In this experiment, DCPD 
cements were synthesized from monocalcium phosphate monohydrate (MCPM) and 𝛽-
tricalcium phosphate (𝛽 –TCP) by using deionized water and sodium citrate as liquid 
components. The samples were prepared with powder to liquid ratio (P/L) at 1.00, 1.25 
and 1.50. To fabricate the PLLA/DCPD composite samples, DCPD samples were coated 
with 5 % PLLA. The samples were characterized mechanical properties, such as porosity, 
diametral tensile strength, and fracture energy. The mechanical properties of DCPD 
scaffolds with and without PLLA coating after the in vitro static degradation (day 1, week 
1, 4, and 6) and in vitro dynamic degradation (day 1, week 1, 2, 4, 6, and 8) were 
investigated by measuring their weight loss, fracture energy, and pH of phosphate buffer 
solution. In addition, the dog bone marrow stromal stem cells (dBMSCs) adhesion on 
DCPD and PLLA/DCPD composite samples were examined by scanning electron 
microscopy. The cell proliferation and differentiation in the medium conditioned with 
DCPD and PLLA/DCPD composite samples were studied by XTT (2,3-Bis(2-methoxy-4-
nitro-5-sulfophenyl)-2H-tetrazolium-5-carboxanilide inner salt), and alkaline phosphatase
xi 
 
(ALP) assay, respectively. The addition of sodium citrate and PLLA coating played a 
crucial role in improving the mechanical properties of the samples by increasing the 
diametral tensile strength from 0.50 ± 0.15 MPa to 2.70 ± 0.54 MPa and increasing the 
fracture energy from 0.76 ±  0.18 N-mm to 12.67 ±  4.97 N-mm. The DCPD and 
PLLA/DCPD composite samples were compatible with dBMSCs and the cells were able 
to proliferate and differentiate in the conditioned medium. The degradation rate of DCPD 
and PLLA/DCPD samples were not significant different (p > 0.05). However, the DCPD 
and PLLA/DCPD composite samples those used sodium citrate as a liquid component 
was found to degrade faster than the groups that use deionized water as liquid component 
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1.  INTRODUCTION 
 
 
1.1 Calcium Phosphate Cements in Bone Tissue Engineering 
Musculoskeletal diseases, such as arthritis, osteoporosis, bone fractures and 
traumas annually cost United States over $250 billion and affect people more than 
hundred millions across the world. About 10 million Americans already have 
osteoporosis, and 34 million are at risk of this disease. In 2005, two million fractures due 
to osteoporosis, which cost over $19 billion, were estimated. Moreover, three million 
fractures and over $25 billion in costs each year will be expected by 2025 [1]. 
Considering the terrible impact of musculoskeletal diseases on the economy and the 
population illustrates the importance of progressing the understanding of musculoskeletal 
disorders through the education and research to improve the quality of life with better 
musculoskeletal conditions. Therefore, the field of tissue engineering has been 
marvelously advanced recently since being described by Vacanti et al. [2] in 1993 as the 
application of  “the principles of engineering and the life sciences toward the 
development of biological substitutes that restore, maintain, or improve tissue function”.  
Although a range of hard tissues including bones and cartilages has been researched, the 
clinical application of engineered hard tissues has been limited. The several current 
therapies of reconstruction of bone defects have been applied, such as autografting and 
allografting, However, these standard treatments still have some limitations. Although 
bone grafts are avascular and depend on the diffusion, the size of defects and the shortage 
of donors still limit these applications. Furthermore, the unpredictable bone resorption 
will be difficult for bone volume maintenance. In large defects, the grafts resorption will 
be completed before osteogenesis is achieved [3]. In addition, the autografting is also 
limited by the additional morbidities due to bone harvesting [4]. A high failure rate of 
allografts was shown due to the risk of disease transmission [3]. These significant 
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drawbacks drive researchers in bone tissue engineering to challenge developing new 
materials for bone grafts and scaffolds that allow for minimally invasive surgical methods 
and provide some of the similar responses to bone. Calcium phosphate cements (CPCs) 
are one of the most interesting materials for scaffolds due to their similarity of bone 
mineral phase and the nature of setting in situ [5]. Therefore, calcium phosphate cements 
(CPCs) have been considered as a bone-defect repair material. 
 
  Calcium phosphate cements (CPCs) were discovered in the early eighties by 
Brown and Chow [6] and LeGeros et al. [7]. They have been categorized into two types: 
apatite CPCs and brushite CPCs. Although both of them are biocompatible, brushite 
CPCs have better resorbability in vivo than apatite CPCs [8].  
 
CPCs are very versatile materials, which draw attention among researchers due to 
their advantages over calcium phosphates ceramic in comparison [9]. First is their 
capacity of self-setting in vivo. Second, their injectability creates excellent prospects for 
minimally invasive surgical techniques. Third, CPCs can be shaped to fit the implant site 
ensuring the good bone-material contact to allow the optimum tissue-biomeaterial contact 
for activating the bone in growth.  Fourth, the dissolution- precipitation process, which 
takes place under in vivo condition, brings about interconnected micro porosity, 
chemistry, and structure, which are similar to biological apatites. Finally, the low-
temperature setting reaction allows CPCs to be incorporated with various drugs, such as 
antibiotics and anti-inflammatory drugs. However, CPCs also have some limitations 
related to their poor mechanical properties, which diminish their applicability from load 
bearing applications [10]. 
 
 
1.2 Statement of Research Question 
First of all, brushite cements have some critical drawbacks; their brittleness and 
low mechanical strength limiting them from load bearing applications. In this research, 
poly-l-lactide acide (PLLA) coated on dicalcium phosphate dihydrate (DCPD) technique 
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was proposed to improve the toughness of DCPD scaffolds.  Moreover, different ratios of 
powder to liquid were determined to improve the mechanical property of DCPD 
scaffolds. In addition, sodium citrate was used as liquid regulator for DCPD preparation 
to improve the mechanical tensile strength of DCPD scaffolds.  
 
Secondly, a critical concern for the development of DCPD scaffolds is the 
degradation of brushite cements. Several studies have shown that DCPD were rapidly 
resorbed under physiological condition [8]. In this study, PLLA coating technique was 
applied to construct the DCPD scaffolds to slow down the degradation of these scaffolds 
during in vitro degradation under both static and dynamic conditions.   
 
Finally, The biocompatibility of brushite cements was well documented under in 
vivo conditions [11, 12]. However, there are only few research focus on the in vitro 
biocompatiblity of DCPD cements [13]. In this study, DCPD and composite 
PLLA/DCPD composite disk samples were fabricated to investigate the biocompatibility 
of the scaffolds.  
 
 
1.3 Thesis Overview 
Chapter 2 provides the overview of the expanding researches for brushite calcium 
phosphate cements. This chapter begins with the classification of calcium phosphate 
cements based on chemical makeup and reaction mechanism. In order to evaluate the 
mechanical property of brushite cements, the current standard methods were explained in 
mechanical property analysis section: diametral tensile strength. Next is to summarize the 
current techniques applying for improving the mechanical properties of brushite cements. 
Finally, the DCPD degradation properties were stated in this chapter.  
 
Chapter 3 provides experimental details to study the effect of material parameters, 
such as the ratios of 𝛽 tricalcium phosphate (𝛽 -TCP) and monocalcium phosphate 
monohydrate (MCPM), size of samples and percentage of PLLA coating. In this chapter, 
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porosity, diametral tensile strength, and fracture energy of the DCPD and PLLA/DCPD 
samples were used to criteria to determine the optimum condition for further 
experiments.  
 
  Chapter 4 provides further experimental details to investigate the effects of setting 
regulator.  Sodium citrate was used as a setting regulator to improve the mechanical 
property of DCPD disk samples. Three material parameters were determined in this 
study: porosity, diametral tensile strength and energy to fracture. In addition, these 
parameters were used to evaluate the best condition for 3D scaffolds.  
 
  Chapter 5 provides experiment details about the effect of PLLA infiltration on 
DCPD disk samples under in vitro static and dynamic degradations. In this experiment, 
pH value, percentage of weight loss and energy to fracture of the disk samples were 
investigated during different degradation periods.  
 
  Chapter 6 states further experimental information about the cytocompatibility of 
DCPD and PLLA/DCPD composite disk samples. Dog bone marrow stromal stem cells 
were used in this study to investigate the cell morphology, proliferation, and 
differentiation. 
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2.  FOUNDATIONS IN CURRENT CALCIUM PHOSPHATE RESEARCH 
 
 
2.1 Introduction 
The increase in the rate of bone fractures have been observed with the aging 
population [14]. Implantation of a temporary or permanent prosthesis, which is a 
challenge for the orthopedic surgeon especially in a large bone defect case, is highly 
demanded for operative treatments. An increasing of bone fractures from high aging 
population and the limitation of bone grafts result in the high clinical demand for bone 
substitutes. Bone substitute materials should be biocompatible, biodegradable at the 
expense of bone growth, and moldable for restoring bone defects [15]. One interesting 
material meeting these requirements is calcium phosphate cement.  
 
 
2.2 Classification of Calcium Phosphate Cements 
  Calcium phosphate cements (CPCs) were discovered by Brown and Chow [16] 
and LeGeros et al. [7] in early eighties. This material has attracted much attention from 
several researchers in bone tissue engineering due to their salient advantages: the ability 
to form direct bond with bone and the low temperature of self-setting reaction under 
physiological conditions [9]. There are two major types of CPCs: apatite cements and 
brushite cements. Apatite cements were studied by several research groups due to their 
resemblance to bone mineral. Moreover, they have more favorable mechanical properties 
and stability at higher pH (pH > 4.2) than brushite (pH < 4.2) [17]. However, brushite 
(dicalcium phosphate dihydrate, DCPD) has been shown for the better ability to resorb in 
vivo over apatite and also promised a material for bone defect filling [8]. DCPD will be 
focused in this study.  
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  The main composition of dicalcium phosphate cements is alkaline calcium source, 
acidic phosphate source, and water. The additive components are also mixed to improve 
the mechanical properties and setting time.  
 
 
2.2.1 Alkaline Calcium Sources 
  Alkaline calcium source in dicalcium phosphate, such as calcium oxide and 
calcium hydroxide are basic [8]. Since the calcium to phosphate ratio in brushite is equal 
to 1, the calcium phosphate compounds containing higher ratios of calcium to phosphate 
can be used as alkaline calcium source for these cements. The most general alkaline 
calcium source for brushite is tricalcium phosphate (TCP) (ratio of calcium to phosphate 
= 1.5), which have two crystallographic forms: 𝛽-TCP and 𝛼-TCP [8]. For this reason, 𝛽-
TCP is more frequently used in brushite cements because it requires lower energy for its 
production [8].  In addition, 𝛽-TCP was used to prepare DCPD in this study. Table 2.1 
summarizes the common alkaline calcium components for dicalcium phosphate.  
 
 
2.2.2 Acidic Phosphate Sources 
  The acidic calcium phosphates used for dicalcium phosphate preparation should 
have a calcium to phosphate ratio lower than one [8]. Since monoclcium phosphate 
monohydrate (MCPM) and monocalcium phosphate anhydrous (MCPA) are the two only 
calcium phosphates that can meet the requirements, they are frequently used for 
dicalcium phosphate preparation [8]. In addition, phosphoric acid is another acidic 
phosphate source commonly used for dicalcium phosphate preparation due to its low cost 
[8]. However, MCPM was used to prepare DCPD in this study due to the novel 
formulation from previous study [18]. Table 2.2 summarizes the general acidic phosphate 
components for dicalcuim phosphate [8].  
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Table 2.1 The summary of the alkaline calcium sources for dicalcium phosphate cements. 
 
Alkaline calcium component 
Name Chemical Formula 
Alpha tricalcium phosphate (α-TCP ) ∝-Ca3(PO4)2 
Beta tricalcium phosphate (β-TCP ) 𝛽-Ca3(PO4)2 
Calcium oxide CaO 
Calcium hydroxide Ca(OH)2 
 
 
Table 2.2 The summary of the acidic phosphate sources for dicalcium phosphate cements. 
 
Acidic phosphate component 
Name Chemical Formula 
Monocalcium phosphate monohydrate (MCPM) Ca(H2PO4)2·H2O 
Phosphoric acid (PA) H3PO4 
Monocalcium phosphate anhydrous (MCPA) Ca(H2PO4)2 
Pyrophosphoric acid (PyA) H4P2O7 
 
 
2.2.3 Additives 
  Besides the reagents required for brushite cements formation, several additives 
are needed to improve the properties of the cements. These additives are usually added to 
the powder or liquid component during cement mixing to improve the setting time and 
mechanical properties. In addition, they are also used to activate the precipitation of 
cements.  Table 2.3 summarizes the general additives and their functions. In addition, 
more effects of the additives on cements will be described in later sections [8].  
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Table 2.3 The summary of the additives for dicalcium phosphate cements. 
 
Additive Function 
Sulfuric Acid Setting time, Mehcanical properties 
Sodium pyrophosphate Setting time, Mehcanical properties 
Citric acid Setting time, Mehcanical properties 
Sodium citrate Setting time, Mehcanical properties 
Magnesium sulfate Setting time, Mehcanical properties 
Tartaric acid Setting time, Mehcanical properties 
Pyrophosphoric acid Setting time, Mehcanical properties 
Glycolic acid Setting time, Mehcanical properties 
Disodium hydrogen phosphate Setting time, Mehcanical properties 
Sodium dihydrogen phosphate Setting time, Mehcanical properties 
 
 
2.3 Chemical Reactions 
  Brushite (Dicalcium phosphate dihydrate, DCPD) cement chemical setting 
reaction consists of four steps: the first one is the dissolution of the cement powder into a 
solvent, the second step is the formation of a super-saturated gel, the third step is the 
nucleation within the gel, and the final step is the growth crystals to a solid of interlocked 
crystals [19].  
 
  The first step starts when MCPM is exposed to the water and hydrolyzed to 
diphosphate and calcium ions following an endothermic reaction (23.0 kJ mole-1) (2.1) 
[19].  Simultaneously, the dissolution of 𝛽-TCP occurrs under exothermic reaction (-66.0 
kJ mole-1) due to the acid exposure from the dissolution of MCPM (2.2) [19]. After the 
initial dissolution of the reagents, the brushite cements are precipitated to form crystals 
under exothermic reaction (-10.0 kJ mole-1) (2.3) [19]. Finally, Equation 2.4 is derived 
from Equation (2.1) + (2.2) + (4* (2.3)), which is exothermic reaction (-83.3 kJ    mole-1) 
[19]. 
 𝐶𝑎(𝐻!𝑃𝑂!)! ∙ 𝐻!𝑂   →   𝐶𝑎!! + 2𝐻!𝑃𝑂!! + 𝐻!𝑂                                                    (2.1) 𝛽 − 𝐶𝑎! 𝑃𝑂! ! + 4𝐻! → 3𝐶𝑎!! + 2𝐻!𝑃𝑂!!                                                         (2.2) 𝐶𝑎!! +   𝐻!𝑃𝑂!! + 2𝐻!𝑂 → 𝐶𝑎𝐻𝑃𝑂! ∙ 2𝐻!𝑂 + 𝐻!                                               (2.3) 
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𝛽 − 𝐶𝑎! 𝑃𝑂! ! + 𝐶𝑎 𝐻!𝑃𝑂! ! ∙ 𝐻!𝑂 + 7𝐻!𝑂 → 4(𝐶𝑎𝐻𝑃𝑂! ∙ 2𝐻!𝑂)                 (2.4) 
 
  The final setting of DCPD cements from 𝛽-TCP and MCPM was reported that 
this setting system took few minutes after mixing [20]. In addition, the nuclear magnetic 
resonance spectroscopy (NMR) study indicated that MCPM completely reacted under the 
chemical setting reaction within the first 20 minutes while some 𝛽-TCP was left under 
unreacted condition [21].  
 
 
2.4 Setting Time Modification 
   Brushite cements have remarkable resorbability and biocompatibility. Since they 
were metastable under physiological conditions, they degraded faster than apatite after 
implantation [22]. However, their short setting times and low mechanical properties limit 
them from broader clinical applications.  
  
  The setting times of brushite cements depend on the solubility of a basic phase or 
the alkaline calcium components. The higher solubility of the basic phase yields faster 
setting time. The setting time of brushite cements depends the solubility of alkaline 
calcium components. For instance, the solubility of 𝛼-TCP is higher than 𝛽-TCP. MCPM 
+  𝛽-TCP needed 30-60 seconds for the setting reaction. In contrast, MCPM + 𝛼-TCP 
needed only few seconds for the setting reaction [15].  
 
  The additives with regarded to Table 2.3 can be applied to modify the setting 
reaction of brushite cements. They inhibit the dissolution of the reagents and the 
precipitation of the crystals [8]. The citrate ions inhibit the dissolution of 𝛽-TCP and 
MCPM during formation of cements [19]. These effects were demonstrated by the 
reduction of the exothermic heat from the cement precipitation leading to the prolonged  
setting time [19].  
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  Brushite crystal is a non-centrosymmetrical monoclinic plate, which has the 
morphology dominated by (0 1 0) faces, consist of two rows of 𝐶𝑎!! and 𝑃𝑂!!! . In 
addition, there are the bonds of layers of water molecules between the calcium phosphate 
sheets. The additives interfere with phosphate incorporation during precipitation limiting 
the crystal growth and the kinetics of growth [8]. Several pyrophosphate compounds and 
sulfate ions are applied to prolong the setting time, such as sodium pyrophosphate, 
pyrophosphoric acid, sulfuric acid, and magnesium sulfate. The addition of low 
concentration of sulfate ions to form the cements can delay the setting time. However, the 
addition of high concentration of sulfate ions resulting in formation of calcium sulfate 
dehydrate crystals acting as the nuclei to accelerate the crystallization of brushite cements 
[8]. The 𝛼-hydroxyl carboxylic acids, such as citric acid, tartaric, and glycolic acid can 
bind to calcium ions to regulate the growth of brushite crystals resulting in the prolonged 
setting time [8].  
 
 
2.5 Mechanical Property Modification 
  According to the standards of American Society for Testing and Materials (ASTM 
5833, 2002), the brushite cements are required to at least set for twenty-four hours before 
testing the mechanical properties for bone cements [8]. In addition, the cement should be 
set and dried under dry condition (room temperature and humidity).  Two types of 
mechanical measurement are used to test the mechanical properties of the cements: 
compressive strength and tensile strength. The brittle materials are difficult to test for the 
direct tensile strength. Therefore, several studies measured the diametral tensile strength 
instead of the direct tensile strength. The mechanical performance of dicalcium phosphate 
cement under compression forces was better than under tensile strains [8].  
  
Small particle sizes of the reagents are applied to improve the mechanical 
properties of the cements. The compressive strength of DCPD cements was increased to 
52 MPa (more than 100%) by adjusting the particle sizes of MCPM and 𝛽-TCP [23].  
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The compressive strength and diametral tensile strength of the cements have 
inverse relationships with their porosity. In addition, reducing porosity results in more 
compaction of the cements and higher strength [8]. The powders to liquid (P/L) ratios 
were applied to regulate the porosity of the cements. A low P/L ratio results in an excess 
of water in the setting reaction yielding too high porosity and low mechanical strength. 
On the contrary, a high P/L ratio results in the improperly mixed cements. Therefore, the 
additives used as the setting regulator are required to improve the mixing condition of 
cements [8]. 
 
The degree of cement setting has a significant effect on its mechanical properties. 
Longer cements setting time yield the higher strength. The additives that used as the 
retardants in the setting systems in regarded to Table 2.3 are applied to improve cements’ 
mechanical properties [8].  
 
The pyrophosphate salts, 𝛼-hydroxyl carboxylic acids, and their salts, such as 
sodium citrate, citric, glycolic and tartaric acids were applied to improve the cements 
mixing with the higher P/L ratios to increase the strength of the cements. However, the 
concentration of these additives needs to be determined to obtain the optimality.  
 
A critical limitation of the cements is their low mechanical properties. Since they 
are brittle, they have low impact resistance and low tensile strength (6 to 10 MPa) [24]. 
On the other hand, their compressive strengths were higher than normal bones after 
implanted for twelve weeks (60-70 MPa) [24]. Moreover, the addition of water soluble 
polymers to the cement liquid phase during cement mixing were applied to improve the 
mechanical properties. For example, polyacrylic acid and polyvinyl alcohol were used to 
improve the mechanical properties of a TTCP + DCPD cement.  The results showed that 
the mechanical properties of the cements were remarkably increased (up to three folds) 
while the setting time significant decreased [25]. In addition, hydrophobic polymer can 
be added to the cement mixture to increase the tensile strength. Gorst et al. reported that 
the addition of polyglactin (PGA) in the form of reinforcing fibers with the optimal 
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arrangement of these fibers on the tensile surface of the cement matrix resulting in the 
increase of the flexural strength up to 7-fold [26]. However, in the case of the fabrication 
of calcium phosphate cement scaffold via casting method, the incorporation of polymer 
during cement mixing might inhibit the casting ability of the cements by blocking the 
channels of the scaffold molds [27]. 
 
Another method to improve the mechanical properties of the calcium phosphate 
cement (CPC) scaffolds is to coat a thin layer of the polymer on the CPC scaffolds.  
However, few studies have applied this technique to the CPC scaffolds. The 3D DCPD 
scaffolds coated with poly(ethylene glycol) diacrylate (PEGDA) showed the 
improvement of flexural strength from 0.44 ± 0.12 MPa to 7.04 ± 0.51 MPa [27]. 
Moreover, DCPD scaffolds coated with poly(propylene fumarate) (PPF) reported the 
increase of the flexural strength from 1.80 ± 0.19 MPa to 16.14 ± 1.70 MPa [28].  
 
In this project, poly-L-lactic acid (PLLA) was chosen to coat on the DCPD 
samples to improve the diametral tensile strength and fracture energy due to its following 
excellent properties. PLLA has been showed to have excellent biocompatibility and 
degradability. Xuan et al. revealed that PLLA had very low degradation rate when 
examining a PLLA with molar mass = 100-300 kDa and percent crytallinity of 50%, 
which was slower than other synthetic polyesters, such as poly(glycolic acid-co-lactic 
acid) and polyglycolic acid (PGA) [29]. In addition, PLLA were non-cytotoxic and not 
totally biological inert. Macrophages and multinucleated giant cells were found to appear 
on the surface of PLLA screws implanted in the sheep bone [30].  
 
 
2.6 Current Mechanical Characterization 
 The demand of the scaffolds for repairing load-bearing bone defects, especially large 
defects, is apparent. In order for the scaffolds to handle the load in cortical and trabecular 
bones, the scaffolds should have the mechanical properties that match to those of the 
natural bone and must be able to maintain the high level of mechanical stability during 
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the implantation. The target properties, such as the diametral tensile strength, fracture 
energy, and the degradation of the scaffolds must be optimized to design the scaffolds 
that account for both the change of properties with the degradation and the change with 
the expected bone ingrowth.  
 
 
2.6.1 In Vitro Degradation 
  Several studies have shown that brushite cements resorbed much faster under 
physiological compared to hydroxyapatite cements [8]. This is one of the most interesting 
advantages of brushite cements. Therefore, it is crucial to understand the mechanism of 
brushite resorption. The degradation of the DCPD consists of 3 mechanisms: dissolution, 
disintegration, and conversion [31-33]. The dissolution starts when the DCPD is placed 
into the solution containing under saturated calcium and phosphate ions. The dissolution 
mechanism leads to the mass loss in DCPD and the decrease of pH values based on the 
following equation: 
 𝐶𝑎𝐻𝑃𝑂! ∙ 2𝐻!𝑂 → 𝐶𝑎!! + 𝐻𝑃𝑂!!! + 2𝐻!𝑂                                                          (2.5) 
 
The high level of DCPD dissolution results in the disintegration of the cements according 
to the changing of its microstructure [33, 34]. In addition, the rate of dissolution of the 
ions from DCPD crystals also depends on the chemical equilibrium between the 
dissolution and recrystallization [32]. Once the solution reaches to the equilibrium, the 
dissolution of DCPD will stop and the mass and pH will stabilize [31, 33]. In the case of 
dynamic degradation, the calcium and phosphate ions will be removed from the solution 
resulting in the further dissolution of DCPD and the reprecipitation of DCPD as HA [33]. 
In the case of static degradation, the solution will become supersaturated with calcium 
and phosphate ions resulting the conversion of DCPD to HA based on Equation 2.6 [31, 
33].  
 10𝐶𝑎𝐻𝑃𝑂! ∙ 2𝐻!𝑂 → 𝐶𝑎!" 𝑃𝑂! ! 𝑂𝐻 ! + 4𝐻!𝑃𝑂! + 18𝐻!𝑂                            (2.6) 
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  The conversion of DCPD to HA results in the formation of phosphoric acid, 
which results in the decreasing of pH values and an increase of solubility of DCPD due to 
their metastable structure at pH > 4.2 [10].  
 
  In the excess of 𝛽-TCP, the final composition is the mixture of DCPD and 
unreacted 𝛽-TCP. The resorption of the unreacted 𝛽-TCP is slower than DCPD. In 
addition, it remains low and stable for long period of time [35]. However, glycolic acid (1 
carboxylic group), tartaric acid (2 carboxylic groups) and citric acid (3 carboxylic 
groups) were used to help the disintegration of 𝛽-TCP. In addition, the more soluble 
calcium carboxylate was found in the solution, the more 𝛽-TCP was released [32].  
 
 
2.6.2 Diametral Tensile Strength 
Brushite cements are known as bone-resembling materials with the excellent 
resorption under physiological conditions and biocompatibility but limited mechanical 
strength [8]. Since one of the important functions of the bone is to support the load in the 
body, the mechanical strength of the brushite cements should be improved and analyzed.  
 
Bone graft and scaffolds are subjected to complex loading in the body, including 
combinations of compression and tension. While cement is strong in compression, its 
tensile strength is usually low and therefore plays a limiting factor in its mechanical 
behavior in vivo. Direct tensile strength of brittle materials is difficult to be measured. 
Therefore, diametral tensile strength is another alternative for tensile measurement.  
 
Demetral tensile strength is known as the indirect tension test for brittle materials, 
such as ceramics and concrete. This test was developed by Carneiro and Barcellos in 
1952 [36]. The test was proceeded by applying the compression load along two opposite 
generators (diametral plane) on the cylinder as shown in Fig. 3.1. The diametral tensile 
strength can be derived from the Equation 3.2.  
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Chow et al. reported that the effect of applying the pressure to the Calcium 
phosphate cements during molding. The cement pastes at P/L = 4.0 were placed into the 
molds and the range of pressure 0-2.8 MPa were applied with the different length of time 
(0.5-4 h). The diametral tensile strength was found to be significantly affected by the 
pressure while no significant effect was found by the time [16].  
 
Van Landuyt et al. indicated that diametral tensile strength was related to the 
conversion of the initial 𝛽-TCP to the DCPD cements. In addition, the higher initial 
MCPM contents promoted the higher coversion of 𝛽-TCP to the DCPD cements resulting 
in lower porosities. Moreover, the optimal diametral tensile strength of DCPD cements 
was achieved at 2.5 MPa [37].  
 
Faleh et al demonstrated that glycolic acid and citric acid delayed the time of the 
setting reaction and limited the cement crystals growth resulting in the more compaction 
of the cements and the increase in the diametral tensile strength. Moreover, the additional ∝ hydroxyl group in carboxylic acid and the solubility of the calcium salt are the main 
factors to limit the brushite setting reaction [20].  
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3.  MECHANICAL CHARACTERIZATION OF DICALCIUM PHOSPHATE 
DIHYDRATE CEMENTS 
 
 
3.1  Introduction 
Dicalcium phosphate dihydrate cements (DCPD) have been widely used as bone 
filling materials owing to their remarkable biocompatibility and bioresorbability. 
However, the low mechanical strength (1 MPa diametral strength) restricted them from 
broader clinical applications [8]. A thin layer of polymer coating is a method applied to 
improve toughness of scaffolds [38, 39]. In this research, poly (L-lactic acid) coating 
technique was applied to DCPD samples fabrication due to their mechanical property, 
biocompatibility and biodegradability [40].  
 
Two types of mechanical assessments have been tested to analyze their 
mechanical properties: diametral tensile strength and fracture energy. Diametral tensile 
strength was measured in this study instead of direct tensile strength due to the difficulty 
in measurement of brittle material even though the measurement of diametral tensile 
strength yield the result of 85% of the true strength of cements [8]. Fracture energy was 
investigated in this study to identify the toughness of the materials. Since porosity was 
inversely correlated to diametral tensile strength of brushite cements, powder to liquid 
ratios were varied in this experiment to adjust the porosity for DCPD samples fabrication.  
 
In this experiment, the ratios of monocalcium phosphate monohydrate 
(MCPM)/𝛽-Tricalcium phosphate (𝛽-TCP) were varied to fabricate DCPD samples in 
order to obtain DCPD samples with high diametral tensile strength. In addition, two 
designs of samples were created and investigated to determine the better designs for 
further experiment. Finally, different percentages of PLLA were coated on the samples to 
investigate the fracture energy of DCPD samples.  
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3.2  Sample Preparation 
Firstly, six groups of DCPD cylindrical samples with different MCPM/𝛽-TCP 
ratios and different powder to liquid (P/L) ratios were fabricated as shown in Table 3.1 to 
investigate the correlation between diametral tensile strength and porosity.  
 
Table 3.1 MCPM/𝛽-TCP ratios for mechanical characterization 
MCPM/𝛽-TCP 
molar ratios 
P/L ratios 
 
1:1 
1.00 
1.25 
1.50 
 
1:3 
1.00 
1.25 
1.50 
 
 
Samples were prepared by measuring the powder components: MCPM (Strem 
Chemicals, New buryport, MA) and 𝛽-TCP (Fluka Chemical corporation, Ronkonkoma, 
NY).  The MCPM and  𝛽-TCP powders were prepared according to the ratios in Table 3.1 
using a balance (Mettler AE 100). The two powders were hand mixed in a mortar to 
ensure homogeneity. Deionized water was used as the liquid component. The powders 
and liquid of different P/L ratios were hand mixed by a metal spatula to ensure that the 
slurry was homogenous. After that, the slurry was casted into a cylindrical Telfon mold 
(5.90 mm diameter and 3.30 mm thickness). After allowing the cements paste to set for at 
least 30 minutes, the samples were removed from the molds. Then, the samples were 
dried in a vacuum desiccator chamber at room temperature for 48 hours.  
 
Secondly, six groups of DCPD samples with MCPM/𝛽-TCP = 1:1 were fabricated 
in two different shapes according to Table 3.2 with the same method as before to identify 
the better design of DCPD samples for further experiment.  
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Table 3.2 DCPD sample designs for mechanical characterization 
 
Design P/L ratios 
 
Cylindrical shape 
(5.8 mm diameter and 4 mm thickness)  
1.00 
1.25 
1.50 
 
Disk shape 
(5 mm diameter and 2.5 mm thickness) 
1.00 
1.25 
1.50 
 
 
Finally, PLLA/DCPD composite samples were prepared. Three groups of DCPD 
disk samples with MCPM/𝛽-TCP = 1:1 were fabricated in different powder to liquid 
ratios (1.00, 1.25 and 1.50) with the same method as above. After that, PLLA pellets were 
first dissolved in dichloromethane (CH2Cl2) solvent (1% and 5% w/w). Then, the DCPD 
disk samples were immersed into PLLA solution under vacuum to completely allow 
PLLA infiltration into the porous cement samples. In this experiment, nine groups of disk 
samples as shown in Table 3.3 were fabricated to investigate the fracture energy of 
samples. 
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Table 3.3 PLLA /DCPD composite samples for mechanical characterization 
 
PLLA/DCPD composite disk samples P/L ratios 
 
Non-coating (control) 
1.00 
1.25 
1.50 
 
1% PLLA coating 
1.00 
1.25 
1.50 
 
5% PLLA coating 
1.00 
1.25 
1.50 
 
 
3.3 Experimental Procedure 
 
 
3.3.1 Porosity of the DCPD Samples Before PLLA Coating 
  The porosity of the DCPD samples were calculated by the following equation:  
 Porosity   % =    1− !!"#$%&!!"#! ×  100                                                                           (3.1) 
 
which “𝜌!"#$%&” is the bulk density and “𝜌!"#!” is the theoretical density of DCPD 
cements, which is 2.318 g/cm3 [27]. Ten samples per group were measured in this 
experiment.  
 
 
3.3.2 Diametral Tensile Strength and Fracture Energy 
Mechanical properties of DCPD and PLLA/DCPD composite samples were 
evaluated using a universal material testing machine (MTS Systems, Eden Prarie, MN).  
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All samples were loaded at a rate of 1 mm/min. The compressive load was applied along 
a diametral plane of the cylinder, as shown in the Fig. 3.1, to determine failure load and 
fracture energy. Ten samples per group were measured for each test in this experiment.  
 
 
 
 
 
 
 
 
Figure 3.1 Diagram showing the compressive loads applied along two generators 
(diametral plane).  
 
 
   Diametral tensile strength 𝜎! (MPa) was calculated based on the failure load P (N) 
that applied to the samples during diametral compresstion test with this following 
equation:    
 
 𝜎! = 2𝑃/𝜋𝐷𝐿                                                                                                                (3.2) 
 
where D = diameter of samples (mm) and L = thickness of samples (mm) [41]. 
  
 
3.3.3  Statistical Analysis 
 Two-way analysis of variance (ANOVA) with the post hoc Tukey-Kramer 
multiple-range test was used to determine the significant differences of the effect of 
MCPM/𝛽-TCP ratios and P/L ratios on the diametral tensile strength. A level of α = 0.05 
P 
P 
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was used for statistical significance. In addition, the effect of P/L on cement porosity, the 
effect of geometry of samples on diametral tensile strength, and the effect of PLLA 
coating on the fracture energy were analyzed using an one-way ANOVA.  
 
 
3.4  Results and Discussion 
 
 
3.4.1 Porosity of DCPD Samples 
It has been shown in several studies that diametral tensile strength of DCPD 
cements was strongly influenced by porosity[8, 27]. In this experiment, the powder to 
liquid (P/L) ratios were adjusted to control the porosity of the cylindrical DCPD samples. 
Increasing the P/L ratios yielded the higher porosity of the cements in the Fig. 3.2 and 
Fig. 3.3. Furthermore, it can be seen in Fig. 3.2 that when P/L ratio increased from 1.00 
to 1.50, the porosity significantly decreased from  63.69  ± 3.40% to 55.15 ± 2.86% (p < 
0.05). Similarly, Fig. 3.3 showed that increasing P/L ratio from 1.00 to 1.50, the porosity 
significantly decreased from  62.50  ± 3.39% to 53.60 ± 5.10% (p < 0.05). In addition, 
the highest porosities of both MCPM/β-TCP ratios were  observed at the P/L = 1.00. 
 
 
 
 
 
 
 
 
 
 
 
 
                          
 
22 
 
 
 
 
 
 
 
 
Figure 3.2 Porosity of cylindrical DCPD samples with MCPM/𝛽-TCP = 1:3 at P/L = 
1.00, 1.25 and 1.50. Marker indicates a significant difference (p < 0.05). 
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Figure 3.3 Porosity of cylindrical DCPD samples with MCPM/𝛽-TCP = 1:1 at P/L = 
1.00, 1.25 and 1.50. Marker indicates a significant difference (p < 0.05). 
 
 
3.4.2  Diametral Tensile Strength Analysis 
  Porosity has a significant effect on the diametral tensile strength of calcium 
phosphate cements [24]. A diametral tensile strength is negative correlated to the 
porosity. In addition, a diametral tensile strength has inversely linear relationship with 
porosity followed a logarithmic trend (Fig. 3.4 and 3.5), which is the characteristic of 
Ryshkewitch relationship [42].  
 𝑆 = 𝑆!exp  (−𝑏𝑝)                                                                                                           (3.3) 
 𝑙𝑛𝑆 = 𝑙𝑛𝑆! − 𝑏𝑝                                                                                                            (3.4) 
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where 𝑆 is  diametral tensile strength of porous samples, 𝑆! is the ideal diametral tensile 
strength at porosity equaled to zero, 𝑏 is an empirical constant, and 𝑝 is the percent 
porosity. The following models are developed based on the Fig. 3.4 and 3.5 respectively:  
 𝑆 = 29.441𝑒!!.!"#!                                                                                                      (3.5)  
 𝑆 = 110.42𝑒!!.!"#!                                                                                                      (3.6)   
 
Based on the Equation 3.6 and Fig. 3.5 , the average of the ideal diametral tensile 
strength at zero porosity was estimated to be 110.42 MPa, which is higher than the 
diametral tensile strength (103 MPa) that was reported by Ishikawa and Asaoka [42]. 
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Figure 3.4 Relationship between the porosity and diametral tensile strength of cylindrical 
DCPD samples at MCPM/𝛽-TCP = 1:3. Tensile strength versus percent porosity was 
plotted for individual samples. The data followed a logarithmic trend was modeled under 
the Ryshkewitch relationship (𝑆 = 29.441𝑒!!.!"#! , where 𝑆  was  diametral tensile 
strength of porous samples, and 𝑝 was the porosity).        
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Figure 3.5 Relationship between the porosity and diametral tensile strength of cylindrical 
DCPD samples at MCPM/𝛽-TCP = 1:1. Tensile strength versus porosity was plotted for 
individual samples. The data followed a logarithmic trend was modeled under the 
Ryshkewitch relationship (𝑆 = 110.42𝑒!!.!"#!, where 𝑆 was  diametral tensile strength 
of porous samples, and 𝑝 was the porosity).          
 
 
Fig. 3.6 indicated that the diametral tensile strength of cylindrical DCPD samples 
with MCPM/𝛽-TCP ratio = 1:3 at P/L = 1.00, 1.25 and 1.50 were 0.28 ± 0.15, 0.42 ± 
0.13, and 0.52 ± 0.22 MPa respectively. In addition, the diametral tensile strength of 
cylindrical DCPD samples with MCPM/-TCP ratio = 1:1 at P/L = 1.00, 1.25 and 1.50 
were 0.34 ± 0.15, 0.65 ± 0.33, and 0.82 ± 0.42 MPa respectively. 
 
The effect of MCPM/  𝛽-TCPs and P/L ratios on diametral tensile strength was 
analyzed by two way Anova. Based on Fig. 3.6, the results demonstrated that the the 
diametral tensile strength of cylindrical DCPD samples at MCPM/  𝛽-TCP = 1:1 were not 
significantly higher than the samples at MCPM/  𝛽-TCP = 1:3. However, the diametral 
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tensile strength of the samples at P/L = 1.5 was significantly higher than the samples at 
P/L = 1.0 at MCPM/  𝛽-TCPs = 1:3. In addition, the diametral tensile strength of the 
samples at P/L = 1.25 was also signifcicantly higher than the samples at P/L = 1.0 whie 
no significant different was found between the samples at P/L = 1.25 and 1.00.   
 
  The excess of 𝛽-TCP might be the cause of the lower diametral tensile strength of 
DCPD samples at MCPM/𝛽-TCP = 1:3. When preparing DCPD from MCPM and 𝛽-
TCP, DCPD was derived under a ceramic-ceramic composite, which was composed of 
the DCPD needle crystals and the remaining of unreacted 𝛽-TCP. The 𝛽-TCP component 
acted as the filler phase while the precipitated DCPD needles acted as the matrix or the 
phase that bound  𝛽-TCP component together. The excess of 𝛽-TCP component for 
deriving DCPD resulted in the higher unreacted 𝛽-TCP contents in DCPD composite, 
which leaded to a lower homogeneity of the cements. Therefore, the DCPD samples that  
contained lower homogeneity would yield lower tensile stregth [22].  
 
  As it can be seen in Fig. 3.6, the group of samples at MCPM/𝛽-TCP = 1:1 at P/L 
= 1.00, 1.25 and 1.50 were chosen to be further investigated due to the higher diametral 
tensile strengths than the groups of MCPM:  𝛽-TCP = 1:3.  
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Figure 3.6 The effect of MCPM/  𝛽-TCP ratios on diametral tensile strength of cylindrical 
DCPD samples. 
 
 
3.4.3 The Effect of the Geometry of DCPD Samples on Diametral Tensile Strength  
To study the effect of geometry of DCPD samples on diametral tensile strength, 
ten DCPD samples at MCPM/𝛽-TCP = 1:1 for each design (disk and cylindrical) were 
fabricated and measured for the diametral tensile strength. Fig. 3.7 indicates that the 
diametral tensile strengths of cylindrical DCPD samples with MCPM/𝛽-TCP ratio = 1:1 
at P/L = 1.00, 1.25 and 1.50 were 0.40 ± 0.15, 0.71 ± 0.33, and 0.88 ± 0.42 MPa 
respectively. In addition, the diametral tensile strength of DCPD disk samples with 
MCPM/𝛽-TCP ratio = 1:1 at P/L = 1.00, 1.25 and 1.50 were 0.14 ± 0.01, 0.18 ± 0.02, 
and 0.23 ± 0.04 MPa respectively. 
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As expected, the geometry of DCPD samples strongly affected on diametral 
tensile strength. In addition, at P/L = 1.25 and 1.50, the diametral tensile strength of 
cylindrical DCPD samples (0.71 ± 0.33 and 0.88 ± 0.42 MPa) were significantly higher 
than the diametral tensile strength of DCPD disk samples (0.01, 0.18 ± 0.02 and 0.23 ± 
0.04 MPa) (p < 0.05). However, there was no significant difference was found between 
the diametral tensile strength of cylindrical DCPD samples and DCPD disk samples at 
P/L = 1.00.  
 
Based on the Equation 3.2 (𝜎! = 2𝑃/𝜋𝐷𝐿  ), the cylindrical DCPD samples  
absorbed higher failure load (P) than DCPD disk samples. However,  the DCPD disk 
samples had smaller diameter (5 mm) and  smaller thickness (2.5 mm)  than the 
cylindrical DCPD samples (5.8 mm diameter and 4 mm thickness). The cylindrical 
DCPD samples yielded greater diametral tensile strength than disk samples due to the 
greater amount of failure load that were absorbed to the cylindrical DCPD, 
 
As a result from Fig. 3.7, the group of DCPD disk samples at MCPM/  𝛽-TCP = 
1:1 were chosen for further experiment according to the smaller standard deviation of 
diametral tensile strength at all P/L ratios (1.00, 1.25 and 1.50). Although, this DCPD 
disk group of samples had lower diametral tensile strength, they were easier to control 
with smaller standard deviation.  
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Figure 3.7 The effect on the geometry of DCPD samples at MCPM/𝛽-TCP = 1:1 on 
diametral tensile strength. Marker indicates a significant difference (p < 0.05). 
 
 
3.4.4 The Effect of PLLA Coating on the Fracture Energy 
To study the effect of PLLA coating on the fracture energy of DCPD disk samples 
at MCPM/𝛽-TCP = 1:1, the samples were frabricated and coated with a thin layer of 
PLLA (1% PLLA or 5% PLLA) and measured for the fracture energy. Fig. 3.8 indicates 
that at P/L 1.50, the fracture energy of the samples with 5% PLLA coating (3.9 ± 1.17 N-
mm) was significantly higher than the control samples (1.35 ± 1.00 N-mm) (p < 0.05). 
However, there is no significant difference of fracture energy found within other P/L 
ratios (P/L = 1.00 and 1.25).  
 
The fracture energy test shows that non-coating PLLA samples (control group) 
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disintegrated due to their brittle property of the cement. However, the composite 
PLLA/DCPD samples retained the overall shape even though they were mechanically 
failed. Two groups of PLLA coated samples (1% and 5% w/w of  PLLA) were showed to 
have higher fracture energy than control groups at all P/L ratios ( 1.00, 1.25 and 1.50). In 
addition, the fracture energy of 5% PLLA samples was significantly higher than control 
group at P/L = 1.50 (p< 0.05) indicating that PLLA matrix played an important role in 
improving the toughness of DCPD samples by binding the sample into a whole body. In 
addition, PLLA have been showed in improving the mechaincal properites of 
hydroxyapatite scaffolds through PLLA coating [43]. 
 
In general, the calcium phosphate cements scaffolds contain open micro cracks in 
the struts after dehydration. The thin layer of PLLA coating filled the pre-existing open 
micro pores and the exposed micro cracks on the surface of the scaffolds and formed an 
interlaced structure. PLLA coatng can improve the fracture energy of DCPD specimens 
because the polymer ligaments stretched upon the crack opening and energy consumption 
during the microcracks propagate to maintain the toughness of DCPD specimens by 
bridging the cracks. To further the experiment, the groups of DCPD samples coated with 
5% PLLA at P/L = 1.00, 1.25 and 1.50 were chosen for further experiment due to the 
higher fracture energy.  
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Figure 3.8 The effect of PLLA coating on the fracture energy of DCPD disk samples at 
MCPM/𝛽-TCP = 1:1. Marker indicates a significant difference (p < 0.05).
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4.  EFFECT OF SODIUM CITRATE 
 
 
4.1 Introduction 
  The purpose of this chapter was to study the effect of sodium citrate on the 
mechanical properties of the DCPD cements. In this chapter, the experiment was 
continued by fabricating DCPD and PLLA/DCPD samples with the chosen condition as 
mentioned in Chapter 3. DCPD and PLLA/DCPD disk samples were fabricated with 
MCPM:  𝛽-TCP = 1:1. In addition, 5% PLLA were coated on DCPD disk samples to 
fabricate the PLLA/DCPD composite samples. The samples were fabricated by using 
sodium citrate and deionized water as the liquid components to compare the mechanical 
properties of the DCPD and PLLA/DCPD composite samples.  
 
 
4.2 Sample Preparation 
  To study the effect of sodium citrate on the mechanical properties of DCPD, six 
groups of DCPD samples were fabricated using MCPM (Strem Chemicals, New 
buryport, MA) and 𝛽-TCP (Fluka Chemical corperation, Ronkonkoma, NY) correlated to 
the ratio of MCPM to 𝛽-TCP = 1:1 at different powder to liquid ratios (P/L): 1.00, 1.25, 
and 1.50. In addition, the first three groups were prepared using deionized water as the 
liquid component at P/L 1.00, 1.25, and 1.50 respectively while another three groups 
were prepared using 100 mM sodium citrate as the liquid component at the same P/L 
ratios. Two powder components (MCPM and 𝛽-TCP) were measured corresponding to 
the molar ratios mentioned above by a balance (Mettler AE 100). The two powders were 
hand mixed in a mortar to ensure homogeneity. Then, the powders and liquid component 
were mixed at different P/L mentioned above by a metal spatula to ensure a homogenous 
slurry. After that, the slurry was casted into an aluminum mold to fabricate DCPD disk 
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samples (5 mm diameter and 2.5 mm thickness). After allowing the cements paste to set 
for 8 min, the samples were removed from the mold. Then, the samples were dried in 
vacuum desiccator chamber at room temperature for 48 h. After drying, the diameter and 
the thickness of the samples were measured by Mitutoyo analog calipers to a tolerance of 
0.01 mm. Then, the weight of each sample was measured using the balance (Mettler AE 
100). 
 
For the composite DCPD/PLLA samples preparation, six groups of DCPD disk 
samples mentioned above were fabricated. After drying, the diameter and the thickness of 
the samples were measured by Mitutoyo analog calipers to a tolerance of 0.01 mm. Then, 
the weight of each fully dried sample was measured using a balance (Mettler AE 100). 
Next, PLLA pellets were first dissolved in chloroform (CHCl3) solvent (1% and 5%). 
After that, the DCPD disk samples were immersed into PLLA solution to completely 
allow PLLA infiltration into the porous cement samples. Then, the samples were dried 
under vacuum in desiccator chamber for 48 h. Finally, the samples were taken out to 
measure the weight using the balance prior to test the mechanical properties.  
 
In this experiment, 10 samples of disk samples with regarded to Table 5.1 were 
fabricated to investigate the porosity, diametral tensile strength, and fracture energy of the 
samples.  
 
 
 
 
 
 
 
 
 
 
                          
 
35 
Table 5.1 Twelve groups of samples for mechanical characterization 
 
Group Liquid phase P/L PLLA 
1 Deionized water 1.00 Uncoated PLLA 
2 Deionized water 1.00 Coated 5% PLLA 
3 Deionized water 1.25 Uncoated PLLA 
4 Deionized water 1.25 Coated 5% PLLA 
5 Deionized water 1.50 Uncoated PLLA 
6 Deionized water 1.50 Coated 5% PLLA 
7 Sodium Citrate  1.00 Uncoated PLLA 
8 Sodium Citrate  1.00 Coated 5% PLLA 
9 Sodium Citrate  1.25 Uncoated PLLA 
10 Sodium Citrate  1.25 Coated 5% PLLA 
11 Sodium Citrate  1.50 Uncoated PLLA 
12 Sodium Citrate  1.50 Coated 5% PLLA 
 
 
4.3 Experimental Procedure 
 
 
4.3.1 Porosity of the DCPD Samples  
  The porosity of the DCPD samples were calculated by the following equation:  
 Porosity  (%) =    1− !!"#$%&!!"#! ×  100                                                                           (3.1) 
 
where “𝜌!"#$%&” is the bulk density and “𝜌!!"#” is the theoretical density of DCPD 
cement, which is 2.318 g/cm3 [27]. Ten samples of each group in the Table 5.1 were 
fabricated to measure the porosity.   
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4.3.2 Diametral Tensile Strength and Fracture Energy 
Mechanical properties of DCPD and PLLA/DCPD composite samples were 
evaluated on a universal materials testing machine (MTS Systems, Eden Prarie, MN).  All 
samples were loaded at a rate of 1mm/min. The compressive load was applied along the 
diametral plane of the cylinder, as shown in Fig. 3.1, to determine failure load and 
fracture energy. Diametral tensile strength was calculated based on Equation 3.2. Ten 
samples per group were measured for each test in this experiment.  
 
 
4.3.3  Statistical Analysis 
 Thee-way and one-way analysis of variance (ANOVA) with the post hoc Tukey-
Kramer multiple-range test were used to determine the significant differences of the 
porosity and the effect of sodium citrate and PLLA coating on the diametral tensile 
strength and the fracture energy. A level of α = 0.05 was used for statistical significance. 
 
 
4.4  Results and Discussion 
 
 
4.4.1 The Porosity  
Several studies have reported that the diametral tensile strength of DCPD cements 
was strongly influenced by porosity [8, 39]. The powder to liquid ratios were used to 
adjust the porosity. Increasing powder to liquid ratios resulted in the reduction of the 
porosity as illustrated in Fig. 4.1 and 4.2. Fig. 4.1 indicated that the porosity of the 
deionized water group at P/L 1.50 (53.57%  ± 2.56%) was siginificantly lower than P/L 
1.25 group (57.44  ± 2.13%) and P/L 1.00 group (58.98  ± 2.36%)  (p < 0.05).  Fig. 4.2 
illustrated that the porosity of the sodium citrate group at P/L 1.00 (59.33%  ± 1.57%) 
was siginificantly higher than the groups at P/L 1.25 (58.82  ± 2.57%)  and P/L 1.50 
(53.19  ± 3.66%)  (p < 0.05).  However, in this experiment only the porosity of the DCPD 
samples was studied. The porosity of PLLA/DCPD samples will be studied in the future. 
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Figure 4.1 Porosity of DCPD samples (Dionized Water, 0% PLLA) at different P/L ratios 
: 1.00, 1.25, and 1.50. Marker indicates a significant difference (p < 0.05). 
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Figure 4.2 Porosity of DCPD samples (Sodium Citrate, 0% PLLA) at different P/L ratios 
: 1.00, 1.25, and 1.50. Marker indicates a significant difference (p < 0.05). 
 
 
 
 
 
 
 
0.00 
10.00 
20.00 
30.00 
40.00 
50.00 
60.00 
70.00 
1.00 1.25 1.50 
Po
ro
si
ty
 (%
) 
P:L 
* 
* 
                          
 
39 
4.4.2  Diametral Tensile Strength Characterization 
To study the effect of sodium citrate, ten samples of each group in Table 5.1 were 
fabricated and determined the diametral tensile strength. From three-way ANOVA, 
sodium citrate had a significant effect on the diametral tensile strength (p < 0.05). The 
diametral tensile strength of the samples with sodium citrate was significant higher than 
those samples with deionized water (p < 0.05). In addition, PLLA coating and P/L ratios 
also had significant effects on the diametral tensile strength. From one-way ANOVA, the 
the results in the Fig. 4.3 indicated the effect of sodium citrate and PLLA coating on 
diametral tensile strength of DCPD specimens. The sodium citrate significantly improved 
the diametral tensile strength of the specimens at all P/L molar ratios. The greatest 
improvement was found at P/L 1.50. The compressive strength of DCPD specimens 
improved from 1.05 ± 0.37 MPa to 1.87 ± 0.27 MPa. The significant effect of PLLA 
coating was showed at all P/L molar ratios for the DCPD specimens preparing from 
sodium citrate. However, the significant effect of PLLA coating was only indicated at 
P/L 1.25 for DCPD specimens preparing from deionized water. The highest diametral 
tensile strength of PLLA/DCPD composite specimens was 1.36 ± 0.22 MPa.  
 
Fig. 4.3 indicates that the P/L ratios, PLLA coating, sodium citrate have 
significant effects on the diamentral tensile strength. The main reason was suggested that 
the diametral tensile strength was found to be related to the porosity of the cement 
samples. Reducing porosity by increasing P/L ratios resulted in the higher mechanical 
strength [8]. In the diametral compression test, the DCPD samples failed and 
disintegrated due to the brittle fracture of the struts. On the other hand, the composite 
PLLA/DCPD samples still retained the overall shape even though they were suffered 
from mechanical failure. Therefore, PLLA coating played an important role in improving 
mechanical properties of the samples by binding the samples into a whole piece. In 
addtion, the load was applied on the diametral plane as mentioned in Fig. 3.1 so the 
tensile strength was affect on the side of the specimens during diametral compression 
test.  As PLLA bridging all DCPD specimen together as a whole piece, the tensile 
strength was maintained by the brigding of PLLA on the side of the specimen. Sodium 
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citrate was also a crucial key to improve mechanical properties of DCPD cements 
because sodium citrate would retard crystal growth resulted in the increase in cement 
compaction due to the reduction of the average crystal size [23].  
 
 
Figure 4.3 The effect of sodium citrate on diametral tensile strength of DCPD and 
PLLA/DCPD composite samples. (Signifcant different within each P/L molar ratio 
compared between two liquid phase and % PLLA coating are indicated by * and ** 
respectively. (n = 10; p < 0.05). 
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addition, the fracture energy of P/L 1.50 groups were significantly higher than P/L 1.25 
and 1.00 groups (p < 0.05). From one-way ANOVA, the result in the Fig. 4.4 indicated 
the effect of sodium citrate and PLLA coating on fracture energy of DCPD specimens. 
Using sodium citrate as the setting regulator improved the fracture energy of the 
specimens at all P/L ratios. The greatest improvement fracture energy was found at P/L 
1.50 and the fracture energy increased from 2.53 ± 1.62 MPa to 6.31 ± 1.05 N-mm. The 
significant effect of PLLA coating was showed at all P/L ratios of the specimens 
preparing from sodium citrate. However, only one significant difference was found on the 
specimens preparing from deionized water at P/L 1.25. The highest fracture energy of 
PLLA/DCPD composite specimens was 12.67 ± 4.97 N-mm.  
 
As mentioned before, the sodium citrate, PLLA, and P/L ratios had the significant 
effects on the fracture energy. The fracture energy was calculated from the area under the 
curve plotted between the load (N) and the displacement (mm). The addition of sodium 
citrate, PLLA coating, and increasing P/L ratios resulted in the increasig of the uder curve 
area and the higher of fracture energy. As mentioned before, the addition of sodium 
citrate resulted in smaller size of the crystals formed and more compaction of the 
cements, leading to the higher under curve area and fracture energy. Increasing the P/L 
ratios resulted in the lower porosity, the higher under curve area, and fracture energy. In 
addition, PLLA coating also increased the fracture energy with the higher under curve 
area due to binding the samples as a whole piece. The difference of the shape of the 
curves bettween 0% PLLA and 5% PLLA group were illustrated in the Fig. 4.3. In 
general, the calcium phosphate cements scaffolds contain open micro cracks in the struts 
after dehydration. The thin layer of PLLA coating filled the pre-existing open micro 
pores and the exposed micro cracks on the surface of the scaffolds and formed an 
interlaced structure. From the load-displacement curve of PLLA/DCPD composite Fig. 
4.4, the load was sharply increased before steep drop and then a small plateau was 
demonstrated. The small plateau was considered as yield resistance increase after coating. 
In this research, the stretch PLLA fibril suggested the toughness of the composite 
scaffolds. According to Pezzotti and Asmus [44], the polymer ligaments stretched upon 
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the crack opening and energy consumption during the microcracks propagate to maintain 
the tougness of DCPD specimens. 
 
 
Figure 4.4 The effect of sodium citrate on fracture energy of DCPD and PLLA/DCPD 
composite samples. (Signifcant different within each P/L molar ratio compared between 
two liquid phase and % PLLA coating are indicated by * and ** respectively. ( n = 10; p 
< 0.05).  
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Figure 4.5 Representative load-displacement curve obtained during dimetral compression 
tests performed on the DCPD samples (Deionized water, P/L = 1.50) : 0 % PLLA and 5% 
PLLA. The fracture energy of 0% PLLA and 5% PLLA were  4.24 and 9.08 (N-mm), 
respectively.  
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5.  IN VITRO DEGRDATION ANALYSIS 
 
 
5.1 Introduction 
  Several studies have reported apatite cements more than brushite cements due to 
their better mechanical properties and the setting ability at neutral pH. However, an 
increasing of the attraction of brushite cement is initiated from their metastability under 
physiological conditions and an ability to resorb in vivo [32].  
 
  In this experiment dicalcium phosphate dehydrate (DCPD) degradation was 
researched by soaking in phosphate-buffered salt solution (PBS). DCPD cements 
fabricated with sodium citrate added to the liquid phase were also studied to investigate 
the influence of sodium citrate on brushite cement degradation. In addition, the PLLA 
was coated on the DCPD samples to investigate the effect of coating during in vitro 
degradation.  
 
To study the in vitro degradation of DCPD and PLLA/DCPD samples, the 
properties, such as pH, mass loss, and energy to fracture were measured during in vitro 
degradation to determine the structural changes during the degradation. The following 
sections will describe the sample preparation and the experiment procedure of samples 
aged by static and dynamic degradation in PBS.  
 
 
5.2 Sample Preparation 
  To study the static degradation in PBS, twelve groups of DCPD samples were 
fabricated using MCPM (Strem Chemicals, New Buryport, MA) and 𝛽-TCP (Fluka 
Chemical, Ronkonkoma, NY) correlated to the molar ratio of MCPM to 𝛽-TCP = 1:1 at 
                          
 
45 
different powder to liquid ratios (P/L): 1.00, 1.25, and 1.50. In this experiment, first three 
groups were fabricated at different P/L as mentioned above using deionized water as the 
liquid component. In addition, 100 mM sodium citrate solution was used as the liquid 
component for the other three groups. Two powder components (MCPM and 𝛽-TCP) 
were measured corresponded to the molar ratios mentioned above with a balance (Mettler 
AE 100). The two powders were hand mixed in a mortar to ensure homogeneity. Then, 
the powders and liquid component were mixed at different P/L mentioned above by a 
metal spatula to ensure a homogenous slurry. After that, the slurry was casted into an 
aluminum mold to form DCPD disk samples (5 mm diameter and 2.5 mm thickness). 
After allowing the cement paste to set for 8 min, the samples were removed from the 
mold. Then, the samples were dried in a vacuum desiccator chamber at room temperature 
for 48 h. After that, the samples were taken out and measured the weight by the balance. 
For the composite DCPD/PLLA samples, six groups of DCPD disk samples mentioned 
above were fabricated. After that, PLLA pellets were dissolved in chloroform (CHCl3) 
solvent (5 %). Then, the DCPD disk samples were immersed into PLLA solution under 
chemical hood. Then, the samples were taken out and dried in vacuum desiccator 
chamber at room temperature for 48 h. Then, the weight of the fully dried samples was 
measured using the balance. In this experiment, twelve groups of DCPD disk samples 
were fabricated according to the Table 5.1. The percentage of weight loss, pH changes, 
and fracture energy was determined during this static degradation study.  
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Table 5.1 Twelve groups of samples for static degradation testing 
 
Group Liquid phase P/L PLLA 
1 Deionized water 1.00 Uncoated PLLA 
2 Deionized water 1.00 Coated 5% PLLA 
3 Deionized water 1.25 Uncoated PLLA 
4 Deionized water 1.25 Coated 5% PLLA 
5 Deionized water 1.50 Uncoated PLLA 
6 Deionized water 1.50 Coated 5% PLLA 
7 Sodium citrate  1.00 Uncoated PLLA 
8 Sodium citrate  1.00 Coated 5% PLLA 
9 Sodium citrate  1.25 Uncoated PLLA 
10 Sodium citrate  1.25 Coated 5% PLLA 
11 Sodium citrate  1.50 Uncoated PLLA 
12 Sodium citrate  1.50 Coated 5% PLLA 
 
 
To study the dynamic degradation in PBS, four groups of DCPD and 
PLLA/DCPD composite samples mentioned in Table 5.2 were chosen for dynamic PBS 
degradation. The percentage of weight loss, pH changes, and fracture energy was 
determined during this static degradation study. 
 
Table 5.2 Four groups of samples for dynamic degradation testing 
 
Group Liquid phase P/L PLLA 
1 
Deionized water 
1.50 Uncoated PLLA 
2 1.50 Coated 5% PLLA 
3 
Sodium citrate 
1.50 Uncoated PLLA 
4 1.50 Coated 5% PLLA 
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5.3. Experimental Procedure 
 
 
5.3.1 In Vitro Static Degradation in PBS 
Twenty samples of each experimental group as in Table 5.1 were prepared for the 
static degradation test. The samples were placed individually in a glass vial containing 3 
ml of PBS at pH 7.4 and incubated at 37℃ for up to 42 days with no soaking media 
changes. Five samples from each group were removed from the incubator at 1, 7, 28, and 
42 days. Then, samples were dried under vacuum in the desiccator chamber for 48 h and 
weighted to determine the percent of weight loss during degradation.  
 
 
5.3.2 In Vitro Dynamic Degradation in PBS 
Thirty-six samples of each experimental group as in the Table 5.1 were prepared 
for the dynamic degradation test. The samples were placed individually in a glass vial 
containing 3 ml of PBS at pH 7.4 and incubated at 37℃ for up to 56 days. In addition, the 
soaking media was changed every 14 days. Six samples from each group were removed 
from the incubator at 1, 7, 14, 28, 42, and 56 days. Then, the samples were dried under 
vacuum in the desiccator chamber for 48 h. After that five samples from each group were 
weighted to determine the percent of weight loss during degradation. Moreover, one 
sample of each group at different time points was taken to observe the surface 
morphology by a scanning electron microscope (SEM, JEOL JSM-5310LV). 
 
 
5.3.3 Mass Loss Testing 
The fully dried samples were weighed to determine the percentage of weight loss 
during degradation.  The percentage of weight loss were calculated with the following 
equation:  
      Percentage  of  weight  loss  (WL  %) =   !!!!!  !! ×  100                                                  (5.1)
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where W0 represents the initial weight of the samples before soaking in PBS and Wd 
denotes the weight of the dried samples after degradation at different time periods [45].  
 
 
5.3.4 pH Testing 
  The pH of the PBS in the each glass vial after removing a sample was measured 
with a pH meter (Denver Instruments, Arvada, CO), which was calibrated with the buffer 
solutions prior to use each time.  
 
 
5.3.5 Fracture Energy Testing 
Fracture energy of each fully dried sample after soaking in PBS at different time 
points was evaluated using a universal materials testing machine (MTS Systems, Eden 
Prarie, MN).  All samples were loaded at a rate of 1mm/min. The compressive load was 
applied along a diametral plane of the samples, as demonstrated before in the Fig. 3.1. 
For both static and dynamic degradation study, five samples from each experimental 
group were measured for each test in this experiment.  
 
 
5.3.6 SEM Analysis 
The surface morphology of the samples was investigated by a scanning electron 
microscope (SEM, JEOL JSM-5310LV). One fully dried sample from each experimental 
group at different time points was sputter coated with gold for SEM analysis.  
 
 
5.3.7 Statistic Analysis 
Quantitative data for weight loss and pH were presented in the form of ± the 
standard deviation. One-way analysis of variance (ANOVA) with the post hoc Tukey-
Kramer multiple-range test was used to determine the significant differences between 
experimental groups. A level of α = 0.05 was used for statistical significance. 
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5.4  Results and Discussion 
 
 
5.4.1  In Vitro Static Degradation  
The percentage of weight loss (WL %) of DCPD and PLLA/DCPD compostie 
samples (without sodium citrate additive) as  a function of immersion time was shown in 
Fig. 5.1. After immersion in PBS solution for 7 days, the P/L :1.00 and 1.50 with 0% 
PLLA groups had lost 3.55 ± 1.47% and 3.78 ± 0.49 % of their masses, respectivetly. In 
addtion the P/L 1.00 (5% PLLA), P/L 1.25 (0% PLLA), P/L 1.25 (5% PLLA), and P/L 
1.50 (5%) PLLA groups lost 2.29 ± 0.41 %, 1.92 ± 0.14 %, 2.44 ± 1.39 %, and 2.41 ± 
0.59 % of their masses, respectively. After day 7, the WL percentage of DCPD and 
PLLA/DCPD samples tended to stablize. Then, the DCPD and PLLA/DCPD composite 
samples started to degrade again after day 28. The final percentage of weight loss on day 
42 of P/L 1.00 (0% PLLA), P/L 1.00 (5% PLLA), P/L 1.25 (0% PLLA), P/L 1.25 (5% 
PLLA), P/L 1.50 (0%), and P/L 1.50 (5%)  groups were 6.57 ± 2.64 %, 5.03 ± 0.72 %, 
5.94 ± 1.01 %, 4.69 ± 1.42 %, 4.83 ± 1.62 %, and 3.67 ± 0.75 %, respectiviely. The 
percentage of weight loss between 0% PLLA and 5% PLLA of each P/L ratio were not 
significant different at each time point (p > 0.05). However, The difference of percentage 
of weight loss between 0% PLLA and 5% PLLA tended to be the largest at P/L = 1.50.  
 
As mentioned in Chapter 2, the 3 in vitro DCPD degradation mechanisms were 
dissolution, disintegration, and conversion [31]. Dissolution started when the samples 
were placed in solution with undersaturated calcium and phosphate ions resulted in mass 
loss during day 1. The high degree of dissolution lead to the cements disintegration 
causing an increase of mass loss after day 1. After 7 days, the solubility limit was reached 
and the solution became saturated. Therefore, the percent weight loss of the samples 
tended to be stabilized during day 7 to day 28. Since DCPD was mestastable at pH > 4, 
the solution became supersaturated. As a results, DCPD was converted to HA leading to 
further mass loss of DCPD after day 28 similar to the studies of Alge et al. [31].  
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The percentage of weight loss (WL %) of DCPD and PLLA/DCPD composite 
samples (with sodium citrate additive) as  a function of immersion time was shown in 
Fig.  5.2. After immersion in PBS solution for 1 day, the P/L 1.00 (5% PLLA), P/L 1.25 
(0% PLLA), P/L 1.25 (5% PLLA), and P/L 1.50 (5%) PLLA groups lost 5.40 ± 0.35 %, 
3.83 ± 1.00 %, 4.46 ± 0.20 %, 3.99 ± 0.43 %, 4.43 ± 0.70 %, and 3.96 ± 0.44 % of 
their masses, respectively. After that, the percentage of weight loss tended to stabilize. 
The percentage of weight loss between 0% PLLA and 5% PLLA of each P/L ratio were 
not significant different at each time point (p > 0.05). However, the difference of 
percentage of weight loss between 0% PLLA and 5% PLLA tended to be hightest at P/L 
= 1.50.  
 
  The dissolution of DCPD cements start when the samples were placed into the 
PBS solution. The high dissolution of DCPD leaded to the disintegradation of cements 
and an increase of mass loss during the first day of immersion. Then, the solution was 
saturated and the weight loss became stabilized. During first week, the degradation of 
DCPD and PLLA/DCPD samples with sodium citrate tended to degrade faster in PBS 
than the samples without sodium citrate additive because sodium citrate was used as a 
setting regulator to inhibit the growth of DCPD crystals formation resulting in small 
DCPD crystals and  leading to more interfacial area between DCPD crystals (without 
sodium citrate additive) and PBS [8]. As a result, the DCPD and PLLA/DCPD samples 
were degraded faster than the samples without sodium citrate additive. In addition, the 
PBS solution tended to be saturated after day 1 while the PBS solution of the other 
samples (without sodium citrate additive) tended to be saturated after day 7.  
 
It is interesting to notice that the results suggest that citrate additive to have a 
stronger effect on the dissolution behaviors of DCPD than the PLLA coating.   
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Figure 5.1 Weight loss of the DCPD and PLLA/DCPD composite samples (no sodium 
citrate additive) during in vitro static degradation.  
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Figure 5.2 Weight loss of the DCPD and PLLA/DCPD composite samples (with sodium 
citrate additive) during in vitro static degradation. 
 
 
The variation of pH of PBS solution as a function of immersiton time of DCPD 
and PLLA/DCPD samples (no sodium citrate additive) was presented in Fig. 5.3.  pH 
value of the PBS sharply decreased after immersion for 1 day. In addtion, the pH of the 
P/L 1.00 (0% PLLA), P/L 1.00 (5% PLLA), P/L 1.25 (0% PLLA), P/L 1.25 (5% PLLA), 
P/L 1.50 (0% PLLA), and P/L 1.50 (5% PLLA) groups dropped to 7.4 to 6.93 ± 0.09, 
6.92± 0.17, 6.81 ± 0.24, 7.07± 0.17, 6.75 ± 0.43, and 6.96± 0.17, respectively. After 
that, the pH of the samples gradually decreased and tended to stabilze during day 7 to day 
28. After day 28, the pH of the P/L 1.00 (0% PLLA), P/L 1.00 (5% PLLA), P/L 1.25 (0% 
PLLA), P/L 1.25 (5% PLLA), P/L 1.50 (0% PLLA), and P/L 1.50 (5% PLLA) were 
sharply reduced to 6.29 ± 0.12, 6.30± 0.10, 6.35 ± 0.23, 6.11± 0.42, 6.25 ± 0.29, and 
6.23± 0.09, respectively. The pH follwed the trend of the percentage of weight loss in 
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disintergradtion, dissolution and high percent of weight loss of the samples. Then, the pH 
tended to stablized and followed the trend of weight loss due to the saturation of the 
solution. After that, the pH values were sharply decreased again due to the further 
degradation of DCPD as mentioned before. The pH value between 0% PLLA and 5% 
PLLA groups at each P/L ratio were not significant different at each time point (p > 
0.05). However, the difference of pH value between 0% PLLA and 5% PLLA tended to 
be hightest at P/L = 1.50.  
 
The variation of pH of the PBS solutions as a function of immersiton time of 
DCPD and PLLA/DCPD samples (with sodium citrate additive is presented Fig. 5.4.  pH 
value sharply decreased after immersion for 1 day. In addtion, the pH solution of the P/L 
1.00 (0% PLLA), P/L 1.00 (5% PLLA), P/L 1.25 (0% PLLA), P/L 1.25 (5% PLLA), P/L 
1.50 (0% PLLA), and P/L 1.50 (5% PLLA) groups were dropped from 7.4 to 6.59 ± 
0.05, 6.60± 0.05, 6.60 ± 0.03, 6.61± 0.02, 6.61 ± 0.04, and 6.57± 0.04, respectively. 
Then, the pH of all the samples tended to stabilize until day 28. After that, the pH of P/L 
1.00 (0% PLLA), P/L 1.00 (5% PLLA), P/L 1.25 (0% PLLA), P/L 1.25 (5% PLLA), P/L 
1.50 (0% PLLA), and P/L 1.50 (5% PLLA) groups gradually decreased to 6.23 ± 0.20, 
6.43± 0.01, 6.10 ± 0.25, 6.08± 0.22, 6.07 ± 0.26, and 6.05± 0.23, respectively. The pH 
values were sharply dropped after immersion for 1 day due to high percentage of weight 
loss as mentioned in Fig. 5.2. Then, the pH tended to stablize followed the trend of 
weight loss due to the saturated solution. After day 28, the pH value decreased a lot while 
the weight loss did not change much due to the high variation of pH values. In addition, 
during the experiment, 3 ml of PBS solution was put in the glass vial to put in the 
incubator as a control group. The result showed that the pH of control group did not 
significantly changed and was maintained at 7.4 during two week. 
 
The pH results again demonstrated a stronger effect of citrate additive to have a 
stronger effect on the pH values during degradation, compared to PLLA coating.  
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Figure 5.3 pH change of the DCPD and PLLA/DCPD composite samples (no sodium 
citrate additive) during in vitro static degradation. 
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Figure 5.4 pH change of the DCPD and PLLA/DCPD composite samples (with sodium 
citrate additive) during in vitro static degradation. 
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energy curves followed the trend of the percent weight loss in Fig. 5.1. After 7 days of 
immersion, the fracture energy curves were gradually decresed due to high percentage of 
weight loss of the samples. Then, the curves were stabilized as the percent weight loss 
were gradually increased and stablized during day 7 to day 28. After that, the fracture 
energy curves tended to increase according to the mass loss of the samples as mentioned 
in Fig. 5.1. The fracture energy of the PLLA/DCPD composite samples were not 
significant higher than the DCPD samples at all P/L ratios except for the initial samples 
before degradation. However, the largest differences of the fracture energy were found 
between the PLLA/DCPD composite samples and DCPD samples at P/L 1.50.  
 
  The fracture energy versus the degradation time curve of DCPD and 
PLLA/DCPD composite samples (with sodium citrate additive) were illustrated in the 
Fig. 5.6. After 7 day of immersion, the fracture energy of the P/L 1.00 (0% PLLA), P/L 
1.00 (5% PLLA), P/L 1.25 (0% PLLA), P/L 1.25 (5% PLLA), P/L 1.50 (0% PLLA), and 
P/L 1.50 (5% PLLA) groups were decreased to 3.00 ± 1.02, 3.62 ± 1.11, 4.28 ± 2.20, 
6.55 ± 2.18, 5.14 ± 2.61, 7.09 ± 3.18 N-mm, respectively. The reduction of the fracture 
energy was due to the high percent weight loss as mentioned from the dissolution and 
disintegration of the cements. After that, the fracture energy of the samples tended to 
stabilized follwing the percent weight loss in the Fig. 5.2 due to the saturation of the PBS 
solution. However, 2 groups of the samples (P/L1.00 (5% PLLA) and P/L 1.25 (5% 
PLLA)) did not follow the stabilized trend due to the high variation. The fracture energy 
of P/L 1.00 (5% PLLA) was increased to 5.72 ±1.58 N-mm while the fracture energy of 
P/L 1.25 (5% PLLA) was further decreased to 3.90 ± 0.78 N-mm. After day 28, the 
fracture energy of the samples still stabilized following the trend of the percent weight 
loss curve. However, the fracture energy of  P/L 1.25 (0%) and P/L 1.50 (5%) were 
increased due to the slightly increased of mass lost with regard to the Fig. 5.2.  
 
The results show that in static degradation, sodium citrate addition has a stronger 
effect than PLLA coating in that the citrate addition leads to a faster degradation, faster 
                          
 
57 
 
pH drop, but higher fracture energy in the samples, compared to samples without citrate 
addition.  
 
 
Figure 5.5 Fracture energy versus immersion time curve of the DCPD and PLLA/DCPD 
composite samples (no sodium citrate additive).  
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Figure 5.6 Fracture energy versus immersion time curve of the DCPD and PLLA/DCPD 
composite samples (with sodium citrate additive).  
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cements.  After that the percentage of weight loss of the samples tended to stabilize due 
to the solubility of DCPD reached the limit so that the PBS solution became saturated. 
After the PBS solution was refreshed on day 14, the percentage of weight loss of the 
samples gradually increased with time. After immersed P/L 1.50 (deionized water, 0% 
PLLA), P/L 1.50 (deionized water, 5% PLLA), P/L 1.50 (sodium citrate, 0% PLLA), and 
P/L 1.50 (sodium citrated, 5% PLLA) groups in PBS solution for 56 day, the percentage 
of weight loss of these samples were 6.32 % ± 0.88 %, 7.12 ± 0.64 %, 7.83 ± 0.25 %, 
and 7.29 ± 0.60 %, respectively. Moreover, the percentage of weight loss between the 
DCPD and PLLA/DCPD samples using sodium citrate as a liquid component were 
significantly higher than the samples using deionized water as a liquid component when 
compared all time points between day 1and  day 42 (p < 0.05). However, the weight loss 
of DCPD samples and PLLA/DCPD composite samples were not significantly different 
during in vitro dynamic degradation (p > 0.05). 
 
 
Figure 5.7 Weight loss of the DCPD and PLLA/DCPD composite samples as a function 
of immersion time during in vitro dynamic degradation. 
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   The pH variation of PBS solution as a function of immersion time is illustrated in 
Fig. 5.8. The pH values of the four groups sharply decreased after immersion in PBS for 
1 day due to the high intial weight loss of the samples. Then, the pH values gradually 
decreased and stabilized during day 1 to day 14 corresponed to the percent weight loss 
curve in the Fig. 5.7. After day 14, the pH values of the samples gradually increased. 
After being immersed for 42 days, the pH of P/L 1.50 (deionized water, 0% PLLA), P/L 
1.50 (deionized water, 5% PLLA), P/L 1.50 (sodium citrate, 0% PLLA), and P/L 1.50 
(sodium citrated, 5% PLLA) groups reached to 6.86 ± 0.10, 6.87 ± 0.10, 6.98 ± 0.10, 
and 6.98 ± 0.10, respectively.  After that , the pH values of P/L 1.50 (deionized water, 
5% PLLA), P/L 1.50 (sodium citrate, 0% PLLA), and P/L 1.50 (sodium citrated, 5% 
PLLA) groups decreased to 6.72 ± 0.09, 6.74 ± 0.31, and 6.85 ± 0.07, respectively.  
However, the pH value of P/L 1.50 (deionized water, 0% PLLA) group did not change.   
 
 
Figure 5.8 Variation of pH values of the DCPD and PLLA/DCPD composite samples as a 
function of immersion time during in vitro dynamic degradation.  
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The fracture energy versus the degradation time curve of DCPD and 
PLLA/DCPD composite samples were illustrated in Fig. 5.9. The overall fracture energy 
of all the groups except P/L 1.50 (deionized water, 0% PLLA) decreased after immersion 
for 56 days. The fracture energy of the P/L 1.50 (deionized water, 0% PLLA) did not 
decreased when compared to day 0 due to the high variation of the initial samples. The 
reason of the decreasing of fracture energy after immersion were probably due to the 
dissolution of calcium phosphate cement phase, which contained soluble salts, [45] and 
transformation of calcium phosphate cements [46, 47]. The conversion of dicalcium 
phosphate dihydrate (DCPD) to dicalcium phosphate anhydrous (DCP) was found to be 
detrimental for the strength of the cements resulted in the decrease of the fracture energy 
of the samples after immersion [46, 47]. 
 
 
Figure 5.9 Fracture energy of the DCPD and PLLA/DCPD composite samples as a 
function of immersion time during in vitro dynamic degradation.  
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  In vitro degradation behavior of DCPD and PLLA/DCPD composite samples in 
PBS solution were investigated through characterizing the variation of the percentage of 
weight loss, the pH value and the fracture energy. The percentage of weight loss of the 
samples increased as time. The changes of the pH values corresponded to the percentage 
of weight loss of the samples. Transformation of brusihte cements to hydroxyapatite 
(HA) was caused by 3 mechanisims: dissolution, disintegration, and conversion [31]. The 
difference of the percentage of weight loss between dynamic and static degradations 
ocurred due to the saturation of the ageing medium (PBS solution) with regarded to 
calcium ions [33]. Since the PBS solution  had no calcium ions, once the samples were 
placed, the DCPD dissolution could begin to increase the amount of calcium and 
phosphate ions in the solution. As a result, the slowing rate of the degradation was 
detected according to higher concentration of calcium and phosphate ions in the solution. 
When the dissolution products were removed every two weeks by refreshing the PBS 
solution, the basis of higher dissolution rate was maintained. In addition, higher 
dissolution also lead to the disintegration of DCPD.  The formation of HA might ocurr 
due to the persistent removal of the ions in the solution allowing the DCPD to dissolve 
and reprecipitate as HA. The decrease of pH after day 28 occurred might because of the 
phosphoric acid, which was a by-product from the conversion of DCPD to HA as 
mentioned in the following equation.  
 10𝐶𝑎𝐻𝑃𝑂! ∙ 2𝐻!𝑂 → 𝐶𝑎!" 𝑃𝑂! ! 𝑂𝐻 ! + 4𝐻!𝑃𝑂! + 18𝐻!𝑂                            (2.6) 
 
The surfaces of the P/L 1.50 (deionized water, 0% PLLA), P/L 1.50 (deionized 
water, 5% PLLA), P/L 1.50 (sodium citrate, 0% PLLA), and P/L 1.50 (sodium citrated, 
5% PLLA) groups during in vitro dynamic degradation were investigated by a scanning 
electron microscope (SEM, JEOL JSM-5310LV) up to 56 days.  
 
The PLLA coating can be clearly seen in Fig. 5.11. Small needle-like 
precipitation can be seen on the surface of the coating on day 7. The precipitation 
becomes very apparent at day 56. The precipitation is presumed to be HA. The actual 
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crystalline nature of the precipitate will be analyzed in the future. Fig. 5.12 shows the 
effect of sodium citrate in inducing a finer crystalline structure in DCPD. The finer 
crystalline structure is presumed to allow a more even PLLA coating seen in Fig. 5.13. 
The PLLA coating can be seen to show porosity starting from day 7. At the same time, 
the needle shape precipitation as seen in the distilled water group are also seen here in the 
sodium citrate samples.   
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Figure 5.10 SEM images of the surface of the DCPD samples (Deionized Water, 0% 
PLLA) after immersion in PBS for 1 day (A), 7 days (B), 14 days (C), 28 days (D), 42 
days (E), and 56 days (F).  
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Figure 5.11 SEM images of the surface of the DCPD samples (Deionized Water, 5% 
PLLA) after immersion in PBS for 1 day (A), 7 days (B), 14 days (C), 28 days (D), 42 
days (E), and 56 days (F).  
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Figure 5.12 SEM images of the surface of the DCPD samples (Sodium Citrate, 0% 
PLLA) after immersion in PBS for 1 day (A), 7 days (B), 14 days (C), 28 days (D), 42 
days (E), and 56 days (F).  
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Figure 5.13 SEM images of the surface of the DCPD samples (Sodium Citrate, 5% 
PLLA) after immersion in PBS for 1 day (A), 7 days (B), 14 days (C), 28 days (D), 42 
days (E), and 56 days (F). 
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6. IN VITRO BIOCOMPATIBILITY ANALYSIS 
 
 
6.1  Introduction 
Brushite has been proved biocompatible and osteoconductive in vivo however 
only a few studies were documented under in vitro condition [8, 13]. In this study, DCPD 
samples with and without PLLA coating were fabricated to investigate the 
cytocompatibility under in vitro condition. In addition, the viability, differentiation, and 
the morphologies of dog bone marrow stromal stem cells (dBMSCs) on the surface of the 
samples were investigated.  
 
 
6.2  Sample Preparation 
  Two groups of samples were prepared using MCPM (Strem Chemicals, New 
Buryport, MA) and 𝛽-TCP (Fluka Chemical corperation, Ronkonkoma, NY) with  the 
ratio of MCPM to 𝛽-TCP = 1:1 and P/L = 1.50. Two different types of solutions were 
used to prepare two major groups of samples. The first major group was fabricated using 
deionized water as a liquid component. The other major group was prepared by using a 
100 mM sodium citrate solution (Fisher Scientific, Pittsburgh, PA) as the liquid 
component. 
 
Two powder components (MCPM and 𝛽-TCP) were measured corresponding to 
the molar ratios mentioned above by a balance (Mettler AE 100). The two powders were 
hand mixed in a mortar to ensure homogeneity. Then, the powders and liquid components 
were mixed at P/L = 1.50 by a metal spatula to ensure a homogenous slurry. After that, 
the slurry was casted into an aluminum mold to form disk samples (5 mm diameter and 
2.5 mm thickness). After allowing the cement paste to set for 8 min, the samples were 
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removed from the mold. Then, the samples were dried in a vacuum desiccator chamber at 
room temperature for 48 h.  
 
For the composite DCPD/PLLA samples preparation, two groups of DCPD disk 
samples (no additive and with sodium citrate additive) as mentioned above were 
fabricated. After that, PLLA pellets were dissolved in chloroform (CHCl3) solvent (5 %). 
The DCPD disk samples were immersed into PLLA solution under chemical hood. Then, 
the samples were taken out and dried in vacuum desiccator chamber at room temperature 
for 48 h. In this experiment, four groups of DCPD disk samples were fabricated 
corresponding to Table 6.1.  
 
Table 6.1 Four groups of samples for biocompatible testing 
 
Group Liquid phase P/L PLLA 
1 
Deionized water 
1.50 Uncoated PLLA 
2 1.50 Coated 5% PLLA 
3 
Sodium citrate 
1.50 Uncoated PLLA 
4 1.50 Coated 5% PLLA 
 
 
6.3. Experimental Procedure 
 
 
6.3.1 Assessment of Cell Viability 
To evaluate the effect of cement on the viability of the dBMSCs, six DCPD disk 
samples of each group corresponding to Table 6.1 were soaked individually with 2 ml of 
phosphate buffer solution (PBS) for 7 days. Moreover, the PBS was changed every 24 h. 
After that, the samples were sterilized by soaking in 70% ethanol for 30 min and washed 
with PBS for two times. Then, the samples were soaked individually in 550 𝜇l of cell 
culture medium (Dulbecco’s modified eagles medium (Invitrogen, Carlsbad, CA) 
supplemented with 10% fetal bovine serum (Atlanta Biologicals, Lawrenceville, GA), 
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and 1% antibiotic-antimycotic solution). After 24 h, the conditioned medium was pipetted 
out to culture the cells.  
 
The effect of the conditioned medium on cell proliferation was evaluated on 
dBMSC as previously described [31]. The cells were placed at 2,000 cells/well in a 96-
well plate. After the cells had attached for one day, they were cultured in 100 𝜇𝑙  conditioned medium that was soaked with a sample for 24 h. The cultured medium 
was changed every second day from the conditioned medium soaking the samples; 
soaking medium of the sample was refreshed at the same time. The test was performed on 
days 1, 3, and 7 with XTT assay. The XTT solution was prepared by mixing 1 mg/ml of 
XTT sodium salt (2,3-Bis(2-methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-5-
carboxanilide inner salt, Sigma-Aldrich, St.Louis, MO) labeling reagent in DMEM 
without phenol red with 0.383 mg/ml of PMS (Phenazine methosulfate, Sigma-Aldrich, 
St.Louis, MO). On each XTT testing day, 50 𝜇l of the XTT solution was added to each 
well of the cell culture well plate and incubated for 4 h at 37℃. Then, 100 𝜇l of solution 
in well was taken to test the spectrophotometrical absorbance of the samples at 450 nm 
using microplate reader (THERMOmax, Molecular Devices) and 650 nm wavelength 
was used as a reference. In addition, standard non-conditioned DMEM medium was used 
as a positive control.   
 
 
6.3.2 Assessment of Alkaline Phosphatase (ALP) 
To evaluate the effect of cement on the differentiation of dBMSCs, six DCPD 
disk samples of each group corresponding to the Table 6.1 were soaked individually with 
2 ml of phosphate buffer solution (PBS) for 7 days. Moreover, the PBS was changed 
every 24 h. After that, the samples were sterilized by soaking in 70% ethanol for 30 min 
and washed with PBS for two times. Then, the samples were soaked individually in 550 𝜇l of cell culture medium (Dulbecco’s modified eagles medium (Invitrogen, Carlsbad, 
CA) supplemented with 10% fetal bovine serum (Atlanta Biologicals, Lawrenceville, 
GA), 1% antibiotic-antimycotic solution) additioned with osteogenic factors (10!! M 
                          
 
71 
 
dexamethansone, 5 𝜇g/ml ascorbic acid, 2-phosphate, and 20 mM 𝛽-glycerophosphate). 
After 24 h, the conditioned medium was pipetted out to culture the cells. 
 
Then, the effect of the conditioned medium on cell differentiation were evaluated 
on dBMSCs via ALP activity as previously described [31]. The cells were placed at 5,000 
cells/well in a 96-well plate. After the cells had attached and proliferated for three days, 
they were cultured in 150 𝜇𝑙  conditioned osteogenic medium that was soaked with a 
sample for 24 h. The cultured medium was changed every second day from the 
conditioned osteogenic medium soaking the samples; soaking medium of the sample was 
refreshed at the same time.  
 
The ALP activity was performed on day 3, 7, and 14 with alkaline phosphatase 
(ALP) assay kit (Sigma-Aldrich, St. Louis, MO). Furthermore, the standard non-
conditioned osteogenic medium was used as a positive control. At each time point, the 
cells were washed with PBS. Then, they were lysed in 0.2% Triton X-100 solution and 
undergone three freeze/thaw cycles (-80/37 °𝐶) for 60 min in total. The cell lysates were 
placed in a 96-well plate to measure the ALP activity with p-nitrophenyl phosphate (p-
NPP) substrate as described in the manufacturer’s manual. The fluorescence was 
measured by a fluorometer (SpectraMax, Molecular Devices) at 360 nm excitation and 
440 nm emission.  
 
 
6.3.3  Cell Morphologies 
To investigate the cell morphologies and cell attachment on the DCPD disk 
samples with and without PLLA coating, six DCPD disk samples of each group 
corresponding to the Table 6.1 were soaked individually with 2 ml of phosphate buffer 
solution (PBS) for 7 days. Moreover, the PBS was changed every 24 hours. After that, the 
samples were sterilized by soaking in 70% ethanol for 30 min and washed with PBS for 
two times. Then, the samples were soaked individually in 550 𝜇l of cell culture medium 
(Dulbecco’s modified eagles medium (Invitrogen, Carlsbad, CA) supplemented with 10% 
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fetal bovine serum (Atlanta Biologicals, Lawrenceville, GA), and 1% antibiotic-
antimycotic solution). After 24 h, the samples were removed and placed into a 96-well 
plate. After that, each sample was seeded with 2000 dBMSCs and incubated in 100 𝜇l 
culture medium. At each time point (Day 1 and 7), the samples were transferred into a 
new 48-well plate and rinsed with PBS (pH 7.4) for two times. Then, they were fixed 
with 4% formaldehyde. The samples were transferred to a new 24-well plate. Then, the 
fixed cells were washed with PBS with for 5 min and followed by sequential dehydration 
in graded ethanol (50%, 70%, 80%, 95%, and 100%, each 10 min). After that, the 
samples were dried in sequential hexamethyldisilizane (HDMS) solution and sputter 
coated with gold for SEM analysis. The morphologies of the cells on the surface of 
samples were observed by a scanning electron microscope (SEM, JEOL JSM-5310LV).   
 
 
6.3.4  Statistical Analysis 
 Three-way analysis of variance (ANOVA) with the post hoc Tukey-Kramer 
multiple-range test was applied to determine significant differences of the XTT and ALP 
results normalized to the positive controls. A level of α = 0.05 was used for statistical 
significance. 
 
 
6.4  Results and Discussion 
 
 
6.4.1  Cell Attachment and Mophologies 
Fig. 6.1 showed the dBMSC morphology on DCPD and PLLA/DCPD composite 
samples after 1 and 7 days of culture. The cells were found to be able to attach and spread 
on the surface of the DCPD and PLLA/DCPD composite samples after seeding for 1 day.  
A slight increased number of cells was observed on DCPD samples (no sodium citrate 
and with sodium citrate additive) when comparing day 7 to day 1. However, the cells, on 
the surface of PLLA/DCPD groups (no sodium citrate and with sodium citrate additive) 
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was difficult to observe via SEM images PLLA coating. Therefore the difference of the 
cell number on the surface of the composites compared between day 1 and day 7 were 
difficult to observe.  
 
 
 
 
 
Day 1 
DCPD  
(No Sodium Citrate Additive)  
PLLA-Coated DCPD  
(No Sodium Citrate Additive)  
Day 1 
DCPD  
(With Sodium Citrate Additive)  
PLLA-Coated DCPD  
(With Sodium Citrate Additive)  
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Figure 6.1 SEM images of the morphology of dBMSCs on the DCPD (with and without 
sodium citrate additive) and PLLA-coated DCPD (with and without sodium citrate 
additive) at day 1 and 7.  
 
 
 
 
 
 
Day 7 
DCPD  
(No Sodium Citrate Additive)  
PLLA-Coated DCPD  
(No Sodium Citrate Additive)  
Day 7 
DCPD  
(With Sodium Citrate Additive)  
PLLA-Coated DCPD  
(With Sodium Citrate Additive)  
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6.4.2  Cell Proliferation 
 The dBMSCs proliferation was investigated by XTT after cultured in the medium 
that conditioned with DCPD and PLLA/DCPD composite samples for 1, 3, and 7 days 
(Fig. 6.2). Fig. 6.2 demonstrated the percentage of cell numbers compared to the positive 
control (standard DMEM medium). From the three-way ANOVA analysis, the results 
showed that day 1 was significantly lower than day 3 (p< 0.05) and day 7 (p< 0.05) but 
day 3 and day 7 were not significantly different from each other. These results suggested 
the cells were still viable regardless of the different trends. Two groups of samples ((no 
additive, 0% PLLA) and (with sodium citrate additive, 5% PLLA)) had shown the cell 
proliferation trend, which was the percentage to positive control increased with the 
incubation time. However, another two groups showed no trends with the incubation 
time.  
 
In addition, the percentage to positive control of 5% PLLA coated DCPD samples 
was significantly higher than 0% PLLA without sodium citrate (p < 0.05) but the effect of 
PLLA coating was not significantly different with sodium citrate groups (P > 0.05).  
Some studies showed that brushite cements caused rapidly decreased pH in vivo after 
implantation [11, 48, 49]. The phenomenon might affect the cell viability on the samples. 
Therefore, coating 5% PLLA on the samples might slow down the pH reduction during 
culture periods resulting in the high percentage to positive control on PLLA-coated 
DCPD samples. The percentage to positive of the samples containing sodium citrate was 
significantly higher than no sodium citrate with 0% PLLA (p <0.05) but sodium citrate 
had no significant effect with 5% PLLA (p > 0.05). These results suggested that the 
DCPD and PLLA/DCPD composite samples were compatible with dBMSCs and the cells 
were able to proliferate in the conditioned medium.  
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Figure 6.2 The percentage to positive control (XTT) of dog bone marrow stromal stem 
cells cultured in the medium conditioned with DCPD or PLLA-coated DCPD samples. 
The standard DMEM medium was used as positive control.  
 
 
6.4.3  Cell Differentiation 
  Alkaline phosphatase is the most commonly recognized early biomarker for 
osteogenic differentiation during the in vitro experiment. Alkaline phosphatase activity of 
dBMSCs cultured in the medium conditioned with the DCPD and PLLA/DCPD (with 
and without sodium citrate additive) samples for 3, 7, and 14 days were demonstrated in 
Fig. 6.3. The figure shows that the ALP enzyme activity of dBMSCs cultured in the 
conditioned medium slightly increased from day 3 to day 7. From three-way ANOVA, the 
ALP enzyme activity significantly decreased on day 14 (p < 0.05). Some studies reported 
that brushite cements caused rapid decrease in pH in vivo after implantation [11, 48]. 
Therefore, the significant reduction of the ALP enzyme activity of dBMSCs on day 14 
might occur because of cell death due to the rapid decrease in pH values during cell 
culture [50]. In addition, the ALP enzyme activity of 0% PLLA groups were significantly 
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lower than 5% PLLA group on day 14 (p< 0.05). This higher ALP enzyme activity of 5% 
PLLA group on day 14 was occurred because PLLA coating slowed down the release 
dissolution of DCPD resulting in the reduction of pH values of the medium. In addition, 
the ALP Enzyme will be further studied by normalizing with amount of protein release in 
the future.  
 
 
Figure 6.3 The quantitative measurement of alkaline phosphatase activity of dog bone 
marrow stromal stem cells cultured in the medium conditioned with DCPD or PLLA-
coated DCPD samples. The standard DMEM medium was used as positive control.  
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7.  CONCLUSION 
 
 
From the results and discussions of this thesis on the dicalcium phosphate 
dihydrate (DCPD) and poly-L-lactide (PLLA)/DCPD composite, several important 
conclusions have been demonstrated as the following:  
 
1. The effect of powder to liquid ratios (P/L), PLLA coating and sodium citrate on the 
mechanical properties of the DCPD cements.  
As demonstrated in Fig. 3.6 and 3.7, the P/L ratios showed a significant effect on 
the diametral tensile strength because increasing P/L ratios resulting in the decrease of 
porosity. In addition, lower porosity leaded to the higher diametral tensile strength. 
Furthermore, decreasing porosity resulting in more compaction of the setting cements and 
higher mechanical strength.  
 
  As illustrated in Fig. 3.8, the PLLA coating was shown to have a significant effect 
on the fracture energy. The diametral compression test showed that DCPD samples failed 
and disintegrated due to their brittleness. However, the PLLA/DCPD composite samples 
retained an overall shape even though they failed mechanically.  In addition, the 5% 
PLLA group was shown to achieve significant higher fracture energy than 0% PLLA 
group. Therefore, PLLA played an important role in improving the toughness of the 
samples by binding the samples into a whole piece.  
 
  As showed in Fig. 4.2, the sodium citrate played a crucial role in improving the 
diametral tensile strength of DCPD and PLLA/DCPD composite samples. Addition of 
sodium citrate as the setting regulator inhibits the growth of the DCPD crystals resulting 
in the increase of cements compaction by reducing the size of DCPD crystals.  
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  Therefore, a combination of the increasing P/L ratios (1.00 to 1.50), the addition 
of 100 mM sodium citrate, and 5% PLLA coating resulted in the improvement of the 
diametral tensile strength of the DCPD samples from 0.50 ± 0.15 MPa to 2.70 ± 0.54 
MPa. In addition, the fracture energy increased from 0.76 ± 0.18 N-mm to 12.67 ± 4.97 
N-mm. 
 
2. In vitro static degradation of DCPD and PLLA/DCPD composite samples (deionized 
water).  
  PLLA/DCPD samples did not show to be significantly different from DCPD 
samples during in vitro static degradation as mentioned in Chapter 5. The weight loss, pH 
changes, and fracture energy of the samples were found to be related to each other. The 
trends of the degradation behaviors for both DCPD and PLLA/DCPD composite samples 
were similar and occurred due to the three mechanisms: dissolution, disintegration, and 
conversion. The cements were first degraded due to dissolution and disintegration. Then, 
they stopped to degrade due to the saturated media. Finally, they started to degrade again 
due to HA conversion. 
 
3. In vitro dynamic degradation of DCPD and PLLA/DCPD composite samples.  
   PLLA/DCPD samples did not show to be significantly different from DCPD 
samples during in vitro dynamic degradation as mentioned in Chapter 5. The DCPD and 
PLLA/DCPD samples (sodium citrate) were found to degrade faster than the samples 
(deionized water) as illustrated Fig. 5.7 during degradation because the sodium citrate 
inhibited the growth of the crystals resulting in smaller size of the crystals and more 
interface area between the crystals and media. As a result, the samples (sodium citrate) 
lost weight more than other groups (deionized Water) during degradation. The weight 
loss, pH changes, and fracture energy of the samples were found to be related to each 
other. As the immersion time increased, the overall weight loss curve tended to increase 
while the fracture energy tended to decrease.  
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4. In vitro cytoocompatibility of DCPD and PLLA/DCPD composite samples.  
  Fig. 6.1, 6.2 and 6.3 illustrated that the cells were able to proliferate and 
differentiate with the medium conditioned with both DCPD and PLLA-coated DCPD 
(deionized water and without sodium citrate). However, PLLA played an crucial role in 
the cell proliferation and differentiation study. The cells were found to proliferate and 
differentiate better in the well plate that contained medium conditioned with the 
PLLA/DCPD samples. The pH of the medium conditioned with DCPD samples rapidly 
decreased during the experiment resulted in cell death. Coating PLLA on the surface of 
DCPD samples slowed down the dissolution of DCPD cements caused by the pH 
reduction and more live cells. As a result, the cells were able to proliferate and 
differentiate better with the medium that conditioned with the PLLA/DCPD composite 
samples 
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